Actively Recruiting
Studying Niacin to Reduce Fat in the Liver for Adults with Metabolic Dysfunction-associated Steatotic Liver Disease MASLD
Led by Université de Sherbrooke · Updated on 2026-07-02
36
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Metabolic dysfunction-associated steatotic liver disease MASLD, also known as non-alcoholic fatty liver disease, is common in people with obesity and type 2 diabetes and can cause liver inflammation and fibrosis due to excess fat in the liver. This study aims to investigate how niacin vitamin B3 affects metabolic responses in adults aged 20 to 80 years with MASLD. Researchers want to find out if niacin can reduce liver fat and increase fat storage in white adipose tissue compared to a placebo. The study is a randomized crossover trial where participants undergo two 12-week treatment phases one with niacin and one with placebo, separated by a 4-week washout period. Niacin or placebo is taken once daily at the end of the largest meal, with a dose escalation over three weeks from 250 mg to 750 mg daily. During each treatment phase, participants have metabolic visits involving test meals, blood sampling, PET scans, and MRI to assess liver and fat metabolism. Participants will attend four metabolic visits lasting nine hours each to measure the effects of niacin on liver fatty acid flux and fat uptake. These visits include advanced imaging and blood tests to evaluate changes in fat metabolism, glucose production, insulin response, and liver inflammation. The study monitors safety and adverse events for up to 28 weeks, with each participant involved for the entire duration of the treatments and assessments.
CONDITIONS
Brief Title
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
Research Team
F
Frédérique Frisch
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here